About LSC

Welcome to





 Institute of Biotechnology   Institute of Biosciences    Institute of Biochemistry



 Our goal - to join the best Life Sciences Institutions of Europe



 Vilnius University Life Sciences Center (LSC) was officially opened on March 15th, 2016. LSC project is implemented by the Vilnius University. This project is one of the so-called Valley programs (research centers) implemented in Lithuania where one of the top priorities is to develop top level University education and attract young researchers to science. LSC total area is 24 thousand square meters at Saulėtekio Avenue 7, nearby the Science Communication and Information Center and National Center for Physical and Technology Sciences.
 The main objective of LSC is to establish a center for research and university education in life sciences by merging biosciences departments of the Faculty of Natural Sciences and Institutes of Biotechnology and Biochemistry. The LSC priorities are top level research and high quality education at Bachelor, Master and PhD level. The Bioincubator which is located in the next building to the LSC hosting new SMEs will pursue process development of biotechnology and molecular medicine.
 Main research fields and study programs at the LSC include structure and functional research of biomolecules, structural biology and bioinformatics, human, plant and microbial genome research, antigenicity studies of recombinant viral proteins and development of monoclonal antibodies, proteomic analysis, molecular medicine, biochemistry, biotechnology, molecular biology, genetics, neurobiology, and related sciences. The aim is to reduce brain drain, encourage brain circulation and creation of new work places especially for young researchers.
 The success of the Lithuanian biotechnology industry starts with well-developed research and education system. With a rich scientific heritage, Lithuania’s biotechnology industry is outpacing developments in many Central and Eastern European countries. Utilizing state of the art technology and the country’s highly skilled talent pool, companies such as Thermo FisherSicor/Teva groupBiotechfarma, etc. are putting Lithuania‘s Life sciences firmly on the map.
 The LSC is focusing on cooperation with business and attracting foreign investments, creation of new innovative business. A team of scientists from the Vilnius University Institute of Biotechnology was one of the first groups to discover that the Cas9 protein could be repurposed to precisely edit targeted sections of an organism's DNA to achieve a specific outcome.  In plants, this can include promoting drought tolerance and disease resistance for protecting plant health and increasing crop yields. Recently DuPont Pioneer announced a technology license and research collaboration agreement with Vilnius University to further the technical and commercial utility of guided Cas9 genome editing technology. Under the agreement, >DuPont received an exclusive license to Vilnius University intellectual property for all commercial uses, including in agriculture. Vilnius University and DuPont have entered into a multi-year research collaboration to advance the development of the technology. In addition, Vilnius University and DuPont have entered into a multi-year research collaboration to advance the development of the technology.